Equity and other equity items (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
| Disclosure Of Share Capital Reserves And Other Equity Interest [Abstract] |
|
| Summary of Shareholder's Equity and Short-term and Long-term Debt |
The amounts of Toyota Motor Corporation shareholders’ equity and short-term and long-term debt are as follows:
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
Toyota Motor Corporation Shareholders’ equity |
|
|
35,924,826 |
|
|
|
39,918,854 |
|
Short-term and long-term debt |
|
|
38,792,879 |
|
|
|
43,205,469 |
|
|
| Disclosure of Classes of Share Capital |
Changes in the shares of common stock issued are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
For the years ended March 31, |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of year |
|
|
16,314,987,460 |
|
|
|
16,314,987,460 |
|
|
|
15,794,987,460 |
|
|
|
|
— |
|
|
|
(520,000,000 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,314,987,460 |
|
|
|
15,794,987,460 |
|
|
|
15,794,987,460 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of Matters Relating to Repurchase |
Details of matters relating to repurchase -
|
|
|
Number of common shares repurchased |
|
64,590,700 shares |
Total purchase price for repurchase of shares |
|
¥150,000 million | Details of matters relating to repurchase -
|
|
|
Number of common shares repurchased |
|
26,880,600 shares |
Total purchase price for repurchase of shares |
|
¥81,037 million | Details of matters relating to repurchase -
|
|
|
Number of common shares repurchased |
|
5,216,600 shares |
Total purchase price for repurchase of shares |
|
¥18,962 million | Details of matters relating to repurchase -
|
|
|
Number of common shares repurchased |
|
420,633,175 shares |
Total purchase price for repurchase of shares |
|
¥1,160,051 million | Details of matters relating to retirement -
|
|
|
|
|
Number of common shares retired |
|
|
520,000,000 shares |
| Details of matters relating to repurchase -
|
|
|
Number of common shares repurchased |
|
16,226,100 shares |
Total purchase price for repurchase of shares |
|
¥39,949 million |
|
| Disclosure Of Detailed Information About Other Components Of Equity |
Other components of equity are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
Remeasurements of defined benefit plans |
|
|
Exchange differences on translating foreign operations |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
933,702 |
|
|
|
— |
|
|
|
1,902,493 |
|
|
|
2,836,195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
|
716,048 |
|
|
|
56,434 |
|
|
|
1,344,621 |
|
|
|
2,117,103 |
|
Reclassification to retained earnings |
|
|
(341,709 |
) |
|
|
(45,625 |
) |
|
|
— |
|
|
|
(387,334 |
) |
Other comprehensive income for the period attributable to non-controlling interests |
|
|
(7,186 |
) |
|
|
(10,809 |
) |
|
|
(44,213 |
) |
|
|
(62,208 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2024 |
|
|
1,300,855 |
|
|
|
— |
|
|
|
3,202,901 |
|
|
|
4,503,756 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
|
44,731 |
|
|
|
(85,084 |
) |
|
|
(705,678 |
) |
|
|
(746,031 |
) |
Reclassification to retained earnings |
|
|
(234,994 |
) |
|
|
94,635 |
|
|
|
— |
|
|
|
(140,359 |
) |
Other comprehensive income for the period attributable to non-controlling interests |
|
|
(1,153 |
) |
|
|
(9,551 |
) |
|
|
3,470 |
|
|
|
(7,233 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2025 |
|
|
1,109,439 |
|
|
|
— |
|
|
|
2,500,693 |
|
|
|
3,610,133 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
|
334,394 |
|
|
|
91,099 |
|
|
|
1,104,451 |
|
|
|
1,529,944 |
|
Reclassification to retained earnings |
|
|
(180,113 |
) |
|
|
(79,403 |
) |
|
|
— |
|
|
|
(259,516 |
) |
Other comprehensive income for the period attributable to non-controlling interests |
|
|
(6,178 |
) |
|
|
(11,696 |
) |
|
|
(52,073 |
) |
|
|
(69,946 |
) |
Transfer to other comprehensive income associated with assets held for sale |
|
|
(148,535 |
) |
|
|
— |
|
|
|
(118,061 |
) |
|
|
(266,596 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2026 |
|
|
1,109,007 |
|
|
|
— |
|
|
|
3,435,012 |
|
|
|
4,544,019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Detailed Information About Other Comprehensive Income And The Corresponding Tax Benefits |
The breakdown of other comprehensive income and the corresponding tax benefits (including non-controlling interests) are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
For the year ended March 31, 2024 |
|
| |
|
|
|
|
|
|
|
|
|
Items that will not be reclassified to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
806,365 |
|
|
|
(248,826 |
) |
|
|
557,539 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
806,365 |
|
|
|
(248,826 |
) |
|
|
557,539 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remeasurements of defined benefit plans |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
57,616 |
|
|
|
(11,289 |
) |
|
|
46,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57,616 |
|
|
|
(11,289 |
) |
|
|
46,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
156,118 |
|
|
|
— |
|
|
|
156,118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
156,118 |
|
|
|
— |
|
|
|
156,118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Items that may be reclassified subsequently to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Exchange differences on translating foreign operations |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
1,178,875 |
|
|
|
— |
|
|
|
1,178,875 |
|
Reclassification to profit (loss) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,178,875 |
|
|
|
— |
|
|
|
1,178,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
33,256 |
|
|
|
(10,459 |
) |
|
|
22,797 |
|
Reclassification to profit (loss) |
|
|
(15,267 |
) |
|
|
4,717 |
|
|
|
(10,550 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,989 |
|
|
|
(5,742 |
) |
|
|
12,247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
182,576 |
|
|
|
— |
|
|
|
182,576 |
|
Reclassification to profit (loss) |
|
|
(16,579 |
) |
|
|
— |
|
|
|
(16,579 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
165,996 |
|
|
|
— |
|
|
|
165,996 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income |
|
|
2,382,959 |
|
|
|
(265,856 |
) |
|
|
2,117,103 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended March 31, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Items that will not be reclassified to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
153,164 |
|
|
|
(51,035 |
) |
|
|
102,129 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
153,164 |
|
|
|
(51,035 |
) |
|
|
102,129 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remeasurements of defined benefit plans |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
(154,517 |
) |
|
|
44,919 |
|
|
|
(109,598 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
(154,517 |
) |
|
|
44,919 |
|
|
|
(109,598 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
(63,213 |
) |
|
|
— |
|
|
|
(63,213 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
(63,213 |
) |
|
|
— |
|
|
|
(63,213 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Items that may be reclassified subsequently to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Exchange differences on translating foreign operations |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
(40,479 |
) |
|
|
— |
|
|
|
(40,479 |
) |
Reclassification to profit (loss) |
|
|
(787,369 |
) |
|
|
— |
|
|
|
(787,369 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
(827,848 |
) |
|
|
— |
|
|
|
(827,848 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
40,503 |
|
|
|
(9,485 |
) |
|
|
31,018 |
|
Reclassification to profit (loss) |
|
|
189 |
|
|
|
(49 |
) |
|
|
140 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
40,693 |
|
|
|
(9,534 |
) |
|
|
31,158 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
127,022 |
|
|
|
— |
|
|
|
127,022 |
|
Reclassification to profit (loss) |
|
|
(5,682 |
) |
|
|
— |
|
|
|
(5,682 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
121,340 |
|
|
|
— |
|
|
|
121,340 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income |
|
|
(730,381 |
) |
|
|
(15,650 |
) |
|
|
(746,031 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The gain on the disposal of certain consolidated subsidiaries was reclassified from “Exchange differences on translating foreign operations” to “Foreign exchange gain (loss), net” in the consolidated statement of income for fiscal 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
For the year ended March 31, 2026 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| Items that will not be reclassified to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
513,231 |
|
|
|
(161,547 |
) |
|
|
351,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
513,231 |
|
|
|
(161,547 |
) |
|
|
351,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remeasurements of defined benefit plans |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
127,129 |
|
|
|
(25,777 |
) |
|
|
101,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
127,129 |
|
|
|
(25,777 |
) |
|
|
101,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
22,331 |
|
|
|
— |
|
|
|
22,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
22,331 |
|
|
|
— |
|
|
|
22,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Items that may be reclassified subsequently to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
| Exchange differences on translating foreign operations |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
946,309 |
|
|
|
— |
|
|
|
946,309 |
|
| Reclassification to profit (loss) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
946,309 |
|
|
|
— |
|
|
|
946,309 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
(78,919 |
) |
|
|
25,603 |
|
|
|
(53,316 |
) |
| Reclassification to profit (loss) |
|
|
185 |
|
|
|
(51 |
) |
|
|
135 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
(78,733 |
) |
|
|
25,552 |
|
|
|
(53,181 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
173,617 |
|
|
|
— |
|
|
|
173,617 |
|
| Reclassification to profit (loss) |
|
|
(12,167 |
) |
|
|
— |
|
|
|
(12,167 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
161,450 |
|
|
|
— |
|
|
|
161,450 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total other comprehensive income |
|
|
1,691,717 |
|
|
|
(161,773 |
) |
|
|
1,529,944 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure Of Detailed Information About Dividends Paid |
Paid dividend amounts are as follows: For the year ended March 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amount of dividends |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on May 10, 2023 |
|
|
Common shares |
|
|
|
474,781 |
|
|
|
35.00 |
|
|
March 31, 2023 |
|
May 26, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on November 1, 2023 |
|
|
Common shares |
|
|
|
405,416 |
|
|
|
30.00 |
|
|
September 30, 2023 |
|
November 22, 2023 | For the year ended March 31, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amount of dividends |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on May 8, 2024 |
|
|
Common shares |
|
|
|
606,338 |
|
|
|
45.00 |
|
|
March 31, 2024 |
|
May 24, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on November 6, 2024 |
|
|
Common shares |
|
|
|
525,991 |
|
|
|
40.00 |
|
|
September 30, 2024 |
|
November 26, 2024 | For the year ended March 31, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amount of dividends |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on May 8, 2025 |
|
|
Common shares |
|
|
|
652,446 |
|
|
|
50.00 |
|
|
March 31, 2025 |
|
May 26, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on November 5, 2025 |
|
|
Common shares |
|
|
|
586,527 |
|
|
|
45.00 |
|
|
September 30, 2025 |
|
November 26, 2025 | Dividends with a record date within the year ended March 31, but with an effective date after the end of that year are as follows: For the year ended March 31, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
Total amount of dividends |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| The Board of Directors Meeting on May 8, 2026 |
|
|
Common shares |
|
|
|
651,697 |
|
|
|
50.00 |
|
|
March 31, 2026 |
|
May 26, 2026 |
|